1. Eder P, Łodyga M, Gawron-Kiszka M, et al. Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Gastroenterology Rev 2023; 18: 1-42.
2.
Raine T, Bonovas S, Burisch J, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis 2022; 16: 2-17.
3.
Chateau T, Feakins R, Marchal-Bressenot A, et al. Histological remission in ulcerative colitis: under the microscope is the cure. Am J Gastroenterol 2020; 115: 179-89.
4.
Black J, Sweeney L, Yuan Y, et al. Systematic review: the role of psychological stress in inflammatory bowel disease. Aliment Pharmacol Ther 2022; 56: 1235-49.
5.
Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 469-73.
6.
Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
7.
Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis. Dis Mon 2019; 65: 100851.
8.
Roda G, Narula N, Pinotti R, et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther 2017; 45: 1481-92.
9.
Huguet JM, Ferrer-Barceló L, Suárez P, et al. Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression? Scand J Gastroenterol 2018; 53: 1286-90.
10.
Anzai H, Hata K, Kishikawa J, et al. Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Dis 2016; 18: 97-102.
11.
Sahami S, Konté K, Buskens CJ, et al. Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis. United European Gastroenterol J 2017; 5: 554-62.
12.
Juczyński Z, Ogińska-Bulik N. Tools for measuring and coping with stress. Psychological Test Laboratory, Warsaw 2009.
13.
Sajadinejad MS, Molavi H, Asgari K, et al. Personality dimensions and type D personality in female patients with ulcerative colitis. J Res Med Sci 2012; 17: 898-900.
14.
Sorokowska A, Słowińska A, Zbieg A, et al. Polish adaptation of Ten Item Personality Inventory test (TIPI) – TIPI-PL – standard and internet version, Wroclaw 2014.
15.
Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-46.
16.
Anzai H, Hata K, Kishikawa J, et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis 2016; 18: 278-82.
17.
Walsh E, Chah YW, Chin SM, et al. Clinical predictors and natural history of disease extension in patients with ulcerative proctitis. Inflamm Bowel Dis 2017; 23: 2035-41.
18.
Hijos-Mallada G, Sostres C, Gomollón F. NSAIDs, gastrointestinal toxicity and inflammatory bowel disease. Gastroenterol Hepatol 2022; 45: 215-22.
19.
Klein A, Eliakim R. Non steroidal anti-inflammatory drugs and inflammatory bowel disease. Pharmaceuticals (Basel) 2010; 3: 1084-92.
20.
Meyer AM, Ramzan NN, Heigh RI, et al. Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 2006; 51: 168-72.
21.
Olczak-Pienkowska A, Hryniewicz Q. Monitoring of antimicrobial consumption – aim, methodology and use. Adv Microbiol 2020; 59: 305-14.
22.
Sun Y, Li L, Xie R, et. al. Stress triggers flare of inflammatory bowel disease in children and adults. Front Pediatr 2019; 7: 432.
